title: Contrast-media induced nephropathy in patients undergoing coronary angiography.
abstract: Contrast-medium induced nephropathy (CIN) in patients undergoing cardiac catheterization has an extremely variable incidence, which is very elevated in high-risk subgroups. Despite its benign course in most cases, it is associated with a longer hospital stay, and elevated in-hospital and late mortality rates. This paper reviews the physiopathogenesis of CIN, as well as the clinical manifestations and preventive measures currently available.
authors.affiliation: Department of Cardiology and Neprhrology, Hospital São Lucas, Pontificia Universidade Católica, Porto Alegre, RS, Brazil.
authors.forename: Vitor O
authors.initials: VO
authors.lastname: Gomes
authors.forename: Patricia
authors.initials: P
authors.lastname: Blaya
authors.forename: Carlos E
authors.initials: CE
authors.lastname: Poli de Figueiredo
authors.forename: Waldomiro
authors.initials: W
authors.lastname: Manfroi
authors.forename: Paulo
authors.initials: P
authors.lastname: Caramori
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D003287:Contrast Media / Q000009:adverse effects; D017023:Coronary Angiography / Q000009:adverse effects* / Q000379:methods; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007677:Kidney Function Tests; D008297:Male; D011322:Primary Prevention / Q000379:methods; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; D014665:Vasodilator Agents